The objectives of this study were to define dietary supplement (DS) use by cancer patients and to investigate factors associated with DS use during cancer treatment.
A cross-sectional survey of adults diagnosed with breast, colorectal, lung, or prostate cancer in 2010-2012 at the University of North Carolina Comprehensive Cancer Center was conducted.